60 related articles for article (PubMed ID: 10596969)
1. A simple acute in vivo comparative test for sensitivity to insulin in the mouse.
Williams CA; Shih MF; Taberner PV
Horm Metab Res; 1999 Oct; 31(10):580-2. PubMed ID: 10596969
[TBL] [Abstract][Full Text] [Related]
2. Comparative three-month study of the efficacies of metformin and gliclazide in the treatment of NIDD.
Noury J; Nandeuil A
Diabete Metab; 1991 May; 17(1 Pt 2):209-12. PubMed ID: 1936478
[TBL] [Abstract][Full Text] [Related]
3. Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes.
Arulmozhi DK; Kurian R; Bodhankar SL; Veeranjaneyulu A
J Pharm Pharmacol; 2008 Sep; 60(9):1167-73. PubMed ID: 18718120
[TBL] [Abstract][Full Text] [Related]
4. Effect of metformin on insulin-stimulated tyrosine kinase activity of erythrocytes from obese women with normal glucose tolerance.
Santos RF; Nomizo R; Bopsco A; Wajchenberg BL; Reaven GM; Azhar S
Diabetes Metab; 1997 Apr; 23(2):143-8. PubMed ID: 9137903
[TBL] [Abstract][Full Text] [Related]
5. The in vivo interaction between gliclazide and glibenclamide and insulin on glucose disposal in the rat.
Tanira MO; Furman BL
Pharmacol Res; 1999 May; 39(5):349-56. PubMed ID: 10328992
[TBL] [Abstract][Full Text] [Related]
6. Effect of rifampin on the pharmacokinetics and pharmacodynamics of gliclazide.
Park JY; Kim KA; Park PW; Park CW; Shin JG
Clin Pharmacol Ther; 2003 Oct; 74(4):334-40. PubMed ID: 14534520
[TBL] [Abstract][Full Text] [Related]
7. Increase of insulin sensitivity in diabetic rats received die-huang-wan, a herbal mixture used in Chinese traditional medicine.
Wu YC; Hsu JH; Liu IM; Liou SS; Su HC; Cheng JT
Acta Pharmacol Sin; 2002 Dec; 23(12):1181-7. PubMed ID: 12466058
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of insulin action and tumor necrosis factor alpha system activity by metformin.
Biarnés J; Fernández-Real JM; Fernández-Castañer M; del Mar García M; Soler J; Ricart W
Metabolism; 2005 Feb; 54(2):235-9. PubMed ID: 15690319
[TBL] [Abstract][Full Text] [Related]
9. Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.
Minoura H; Takeshita S; Yamamoto T; Mabuchi M; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Ita M; Mutoh S
Eur J Pharmacol; 2005 Sep; 519(1-2):182-90. PubMed ID: 16039648
[TBL] [Abstract][Full Text] [Related]
10. Membrane physiology as a basis for the cellular effects of metformin in insulin resistance and diabetes.
Wiernsperger NF
Diabetes Metab; 1999 Jun; 25(2):110-27. PubMed ID: 10443322
[TBL] [Abstract][Full Text] [Related]
11. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
12. Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: a model-based approach.
Xu L; Man CD; Charbonnel B; Meninger G; Davies MJ; Williams-Herman D; Cobelli C; Stein PP
Diabetes Obes Metab; 2008 Dec; 10(12):1212-20. PubMed ID: 18476982
[TBL] [Abstract][Full Text] [Related]
13. Effect of chronic rosiglitazone, metformin and glyburide treatment on beta-cell mass, function and insulin sensitivity in mZDF rats.
Atkinson LL; McDonald-Dyck C; Benkoczi C; Finegood DT
Diabetes Obes Metab; 2008 Sep; 10(9):780-90. PubMed ID: 17970758
[TBL] [Abstract][Full Text] [Related]
14. Metformin does not alter diabetes incidence in the NOD mouse.
Beales PE; Giorgini A; Annovazzi A; Signore A; Parlapiano C; Pozzilli P
Horm Metab Res; 1997 Jun; 29(6):261-3. PubMed ID: 9230345
[TBL] [Abstract][Full Text] [Related]
15. Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic mice.
Matsuyama-Yokono A; Tahara A; Nakano R; Someya Y; Shiraki K; Hayakawa M; Shibasaki M
Metabolism; 2009 Mar; 58(3):379-86. PubMed ID: 19217455
[TBL] [Abstract][Full Text] [Related]
16. Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure.
Kokić S; Buković D; Radman M; Capkun V; Gabrić N; Lesko V; Karelović D; Stancerić T
Coll Antropol; 2003 Jun; 27(1):181-7. PubMed ID: 12974145
[TBL] [Abstract][Full Text] [Related]
17. Effect of metformin treatment on glucose tolerance and glomerulosclerosis in KK mice.
Reddi AS; Jyothirmayi GN
Diabete Metab; 1993; 19(1):44-51. PubMed ID: 8504884
[TBL] [Abstract][Full Text] [Related]
18. Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetic subjects.
Formoso G; De Filippis EA; Michetti N; Di Fulvio P; Pandolfi A; Bucciarelli T; Ciabattoni G; Nicolucci A; Davì G; Consoli A
Diabetes Metab Res Rev; 2008; 24(3):231-7. PubMed ID: 17966969
[TBL] [Abstract][Full Text] [Related]
19. Effect of acute and sub-chronic administration of the imidazoline compound S 22068 on in vivo glucose and insulin responses in normal lean CBA/Ca mice.
Williams CA; Shih MF; Taberner PV
Gen Pharmacol; 2000 Mar; 34(3):183-91. PubMed ID: 11120380
[TBL] [Abstract][Full Text] [Related]
20. Effects of metformin and vanadium on leptin secretion from cultured rat adipocytes.
Mueller WM; Stanhope KL; Gregoire F; Evans JL; Havel PJ
Obes Res; 2000 Oct; 8(7):530-9. PubMed ID: 11068959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
